5news.Canadian news, all in one place

BREAKING

› Trump faces midterm fuel reckoning as gas prices near Biden’s average › Maple Leafs announce John Tavares out on week-to-week basis › TFC coach Robin Fraser suspended for match against New York Red Bulls › Raptors convert centre Nate Bittle to two-way contract, waive five › Canada's Dabrowski, Brazilian partner Stefani advance to doubles final at Wuhan Open › CHAUDHRI: Canadian small businesses falling behind on AI. Is caution costing us?› NDP says it opened or expanded 250 schools while B.C. Liberals closed 250. Is that accurate?› B.C. municipal election day 2026: Polls open across the province › B.C. Municipal Election Day Live: The latest news, results and reaction › Vancouver Election 2026: Voters to decide whether Ken Sim gets second term › Trump faces midterm fuel reckoning as gas prices near Biden’s average › Maple Leafs announce John Tavares out on week-to-week basis › TFC coach Robin Fraser suspended for match against New York Red Bulls › Raptors convert centre Nate Bittle to two-way contract, waive five › Canada's Dabrowski, Brazilian partner Stefani advance to doubles final at Wuhan Open › CHAUDHRI: Canadian small businesses falling behind on AI. Is caution costing us?› NDP says it opened or expanded 250 schools while B.C. Liberals closed 250. Is that accurate?› B.C. municipal election day 2026: Polls open across the province › B.C. Municipal Election Day Live: The latest news, results and reaction › Vancouver Election 2026: Voters to decide whether Ken Sim gets second term

Business

Teva to Host R&D Day on Wednesday, November 11 in New York City

Financial Post · October 12, 2026 at 5:49 p.m.

TEL AVIV, Israel, Oct.

12, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will host an R&D Day on Wednesday, November 11, 2026.

At the R&D Day, Teva’s leadership will discuss its R&D pipeline, its near-term value-creation potential over the next five years, and Teva’s ongoing transformation into an innovative biopharma company through the Pivot to Growth strategy.

Read More

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

The Alberta referendum in focus: FP Video explores

Financial Post · 4 h ago

Risk of an AI crunch for stock markets is rising

Financial Post · 5 h ago

William Watson: In new pamphlet, U.K.’s Kemi Badenoch points the (right) way

Financial Post · 5 h ago

Pipeline, major projects shows Ottawa’s commitment to Alberta, Smith says

Financial Post · 5 h ago

More in Business

The Alberta referendum in focus: FP Video explores

Financial Post · 4 h ago

Risk of an AI crunch for stock markets is rising

Financial Post · 5 h ago

William Watson: In new pamphlet, U.K.’s Kemi Badenoch points the (right) way

Financial Post · 5 h ago

Pipeline, major projects shows Ottawa’s commitment to Alberta, Smith says

Financial Post · 5 h ago

Phoenix Tailings Advances Rare Earth Separation Engineering

Financial Post · 15 h ago

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

Financial Post · 16 h ago